ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC17196-5mg |
|
422513-13-1 |
Hesperadin
|
0 | C29H32N4O3S | |
GC17195-10mM (in 1mL DMSO) |
|
579492-81-2 |
Bax inhibitor peptide V5
|
0 | C27H50N6O6S | |
GC17195-100mg |
|
579492-81-2 |
Bax inhibitor peptide V5
|
0 | C27H50N6O6S | |
GC17195-10mg |
|
579492-81-2 |
Bax inhibitor peptide V5
|
0 | C27H50N6O6S | |
GC17195-5mg |
|
579492-81-2 |
Bax inhibitor peptide V5
|
0 | C27H50N6O6S | |
GC17194-250g |
|
7558-80-7 |
Sodium phosphate monobasic
|
0 | NaH2PO4 | |
GC17193-5mg |
|
149635-73-4 |
MOG (35-55)
|
0 | C118H177N35O29S | |
GC17193-1mg |
|
149635-73-4 |
MOG (35-55)
|
0 | C118H177N35O29S | |
GC17192-10mg |
|
97548-97-5 |
Quinelorane hydrochloride
|
0 | C14H22N4.2HCl | |
GC17191-1g |
|
521984-48-5 |
SIS3 HCI
|
0 | C28H28ClN3O3 | |
GC17191-500mg |
|
521984-48-5 |
SIS3 HCI
|
0 | C28H28ClN3O3 | |
GC17191-25mg |
|
521984-48-5 |
SIS3 HCI
|
0 | C28H28ClN3O3 | |
GC17191-5mg |
|
521984-48-5 |
SIS3 HCI
|
0 | C28H28ClN3O3 | |
GC17191-2mg |
|
521984-48-5 |
SIS3 HCI
|
0 | C28H28ClN3O3 | |
GC17190-50mg |
|
1408245-02-2 |
galacto-Dapagliflozin
|
0 | C21H25ClO6 | |
GC17190-10mg |
|
1408245-02-2 |
galacto-Dapagliflozin
|
0 | C21H25ClO6 | |
GC17190-5mg |
|
1408245-02-2 |
galacto-Dapagliflozin
|
0 | C21H25ClO6 | |
GC17190-1mg |
|
1408245-02-2 |
galacto-Dapagliflozin
|
0 | C21H25ClO6 | |
GC17189-50mg |
|
1215766-76-9 |
NBI 27914 hydrochloride
|
0 | C18H20Cl4N4.HCl | |
GC17189-10mg |
|
1215766-76-9 |
NBI 27914 hydrochloride
|
0 | C18H20Cl4N4.HCl | |